title: Case of de novo psoriasis possibly triggered by nivolumab.
authors.affiliation: Department of Dermatology, Shimane University Faculty of Medicine, Izumo, Japan.
authors.forename: Susumu
authors.initials: S
authors.lastname: Murata
authors.affiliation: Department of Dermatology, Shimane University Faculty of Medicine, Izumo, Japan.
authors.forename: Sakae
authors.initials: S
authors.lastname: Kaneko
authors.affiliation: Department of Surgical Pathology, Shimane University Faculty of Medicine, Izumo, Japan.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Harada
authors.affiliation: Department of Otorhinolaryngology, Shimane University Faculty of Medicine, Izumo, Japan.
authors.forename: Noriaki
authors.initials: N
authors.lastname: Aoi
authors.affiliation: Department of Dermatology, Shimane University Faculty of Medicine, Izumo, Japan.
authors.forename: Eishin
authors.initials: E
authors.lastname: Morita
mesh_terms: D000279:Administration, Cutaneous; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009367:Neoplasm Staging; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors / Q000378:metabolism; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000473:pathology; D015398:Signal Transduction / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology; D058504:Th17 Cells / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004338:Drug Combinations; D061026:Programmed Cell Death 1 Receptor; C517164:betamethasone dipropionate, calcipotriol drug combination; D000077594:Nivolumab; D001623:Betamethasone; D002117:Calcitriol